the effect of transdermally administered scopolamine ( tts-scopolamine ) ( 2.5 cm2 surface area , one and two patches ) and dimenhydrinate ( 100 mg ) on experimental motion sickness was examined in 16 healthy volunteers in a randomized double-blind study .
C0036442
scopolamine
C0026603
motion sickness